Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview (Q33925669)

30 July 2017

1 reference

title

Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview (English)

1 reference

30 July 2017

1 reference

Shaw LM

1

1 reference

PubMed ID

10823369

30 July 2017

Kaplan B

series ordinal

2

1 reference

PubMed ID

10823369

30 July 2017

Brayman KL

series ordinal

3

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

Clinical Therapeutics

1 reference

30 July 2017

22 Suppl B

1 reference

30 July 2017

B1-13

1 reference

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

A Putative Sirolimus (Rapamycin) Effector Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Mechanism of action of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Contemporary immunosuppression in renal transplant recipients: one size does not fit all.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

An immunoassay for the measurement of sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Pharmacokinetics and metabolism of sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989018-9

7 January 2021

10.1016/S0149-2918(00)89018-9

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10823369